Boston Medical Group

Boston Medical Group review

SlimFitRx pricing that needs an itemized reconciliation. The costs, commitments and questions worth considering.

GLP1 Rank is a commercial comparison site. We may earn a commission through links. How we’re funded

Our take

Boston Medical Group offers a physician-guided program with published cost information, but the pages do not agree on the full purchase. I would resolve the platform fee, formulation and next charge before enrolling.

Reasons to look closer

  • Dedicated program and cost pages
  • Monthly shipment process described
  • A published cancellation statement

Keep in mind

Public pricing pages conflict. Older formulation language also needs clarification against the actual prescription.

The costs at a glance

Published price reference$199/advertised month
SlimFitRx advertised starting price
MedicationCompounded semaglutide or tirzepatide described in SlimFitRx materials
CommitmentProgram-page cancellation affects next month after shipment begins; confirm selected term
Important contextCurrent cost page lists $699 for twelve weeks and a $199 monthly reference; a separate program-steps page lists $999 with $299 monthly pricing. Obtain a current itemized quote.

The first task is to reconcile the price pages

Boston Medical Group’s cost page advertises getting started from $199 monthly, with a $699 twelve-week total, while its FAQ describes $199 to $299 depending on medication strength. A different program-steps page quotes $299 monthly and a $999 twelve-week total with a telemedicine platform fee. I would not silently choose the cheapest version. Ask the team for the named prescription, the amount charged today and the full cost of the recommended course. That written quote is more useful than a starting figure that may belong to a different plan. A review should make this discrepancy visible because it changes the budget before any judgment about the value of remote care. Read our complete-cost guide for the next questions to work through.

Ask whether the platform fee is an additional required charge

The program-steps page describes a $100 telemedicine platform fee beside the $299 monthly figure. The cost page instead pairs its $199 monthly reference with a $699 twelve-week total. Both totals imply additional cost beyond three base monthly charges; neither should be treated as a definitive checkout invoice without confirmation. I would ask whether the fee is one-time, recurring or limited to a particular version of the program. Also confirm what is included in the medication price, especially supplies and follow-up visits. A platform charge can be reasonable when its purpose and frequency are clear; the problem is counting it incorrectly or omitting it from a comparison. Keep the complete first-course total and next-course price beside the headline before deciding whether the offer fits.

SlimFitRx is a treatment program, not a guaranteed prescription

The overview describes compounded semaglutide and tirzepatide within a medication-and-lifestyle program. The process begins with a consultation and a licensed physician deciding what to prescribe. I would ask what records are required, how the clinical review takes place and what happens if a medication is not appropriate. The initial conversation is an opportunity to clarify the formulation and monitoring, rather than a commitment to a particular drug from a menu. A remote service can be convenient, but its practical value comes from the prescriber’s ongoing availability and clear follow-up, not just the ability to complete an online form.

A monthly delivery description needs a specific supply plan

Program materials describe monthly delivery with syringes and alcohol swabs. I would confirm the actual quantity, concentration and number of weeks for the prescribed order before comparing the cost with another provider. Those details also matter if the clinician changes the treatment. Ask how refill requests are reviewed and when another charge occurs relative to shipment. A delivery schedule is not a dosing instruction, and a previous vial’s instructions may not apply to a new preparation. Keep the current label and pharmacist contact available. The package should be understandable without relying on a generic chart or calculation from a different prescription.

Cancellation timing is linked to shipment processing

The program-steps page says treatment can be cancelled at any time, but if shipment has begun the program cancels in the following month. I would ask for the next processing date and written confirmation of the effective cancellation. The wording does not establish a universal refund for medication already prepared or dispatched. A request to stop care and a request to stop the next payment should both be explicit. If considering a longer financial commitment, obtain the applicable exit policy before paying. Knowing which shipment has started is more actionable than relying on a general cancel-anytime message after another order is already underway. Read our cancellation guide for the next questions to work through.

Older formulation wording deserves a direct question

An older SlimFitRx page discusses salt forms such as semaglutide acetate. FDA says these salts differ from the active ingredient in approved drugs and that it is not aware of a lawful basis for their use in compounding. That older page does not prove what an individual patient would receive today, but it is a reason to ask for the exact formulation and pharmacy before purchase. I would not repeat the page’s equivalence language as reassurance. Obtain a clear explanation from the clinician and pharmacist, and distinguish current prescribing information from older marketing copy. The actual prescription matters more than a shared ingredient name. Read our pharmacy verification guide for the next questions to work through.

Research percentages are not a personal forecast

The treatment overview uses weight-loss percentages to explain why these medicines attract interest. I would ask which product and study support a particular claim, especially when a commercial page also describes compounded preparations. Results from a branded-drug trial are not proof that a different formulation or entire telehealth program produces the same outcome. This does not make research irrelevant; it makes the study conditions important. Keep the evidence question separate from the quote. The most useful clinical discussion explains suitability, follow-upandside-effect support for an individual, rather than promising that the headline average will happen after enrollment.

My assessment: clarify the offer before comparing value

I would keep Boston Medical Group on a research shortlist for someone interested in its remote physician-guided program, but would not rank its value from the $199 headline alone. The complete fee, the current formulation and the applicable shipment policy need reconciliation. Those are answerable questions that should be settled before payment. Compare Found if you are exploring several medication and care pathways, or Amble for another term-based direct-pay arrangement. Neither comparison establishes clinical equivalence. The practical decision should rest on a clear current quote and prescribing relationship, rather than the most favorable line among several pages.

Before you sign up

  • Which $199 or $299 offer applies to the prescription?
  • Is the $100 platform charge required and how often?
  • What exact formulation and pharmacy will fulfill the order?

Use the answers to compare the exact offer with another provider. A service review cannot determine whether a medication is appropriate for you; that decision belongs with your clinician.

Compare the complete budget · Save your provider checklist

Research the questions behind this offer

Further reading

Other providers to compare

Compare a broader mix of care and medication pathways.

Found

Several care and payment pathways

Found

$149/4 weeks

Branded-plan cash-pay membership

One-period plan; branded medication and applicable labs are extra. Other plans have different terms.

Compare another direct-pay plan and commitment structure.

Amble

A short-plan price with longer-term tradeoffs

Amble

$179/advertised month

One-month compounded GLP-1 plan reference

Named prescription and checkout control. Six-month tables conflict ($135 versus $145 monthly equivalent); bulk terms are prepaid and refunds depend on pharmacy transmission.

One more option